109 related articles for article (PubMed ID: 6661511)
1. Bioavailability of medroxalol in man.
Keeley FJ; Weiner DL; Okerholm RA
Biopharm Drug Dispos; 1983; 4(4):305-9. PubMed ID: 6661511
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonist.
Haegele KD; Jaillon P; Cheymol G; Alken RG; Schechter PJ; Koch-Weser J
Clin Pharmacol Ther; 1983 Dec; 34(6):785-91. PubMed ID: 6641094
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
Elliott HL; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
5. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
[TBL] [Abstract][Full Text] [Related]
6. [The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride].
Grobecker H; Kees F; Linden M; Schrader E; Welte S
Arzneimittelforschung; 1987 Apr; 37(4):447-50. PubMed ID: 2440455
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioavailability of the anti-emetic agent bromopride.
Brodie RR; Chasseaud LF; Darragh A; Lambe RF; Rooney L; Taylor T
Biopharm Drug Dispos; 1986; 7(3):215-22. PubMed ID: 3730521
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
[TBL] [Abstract][Full Text] [Related]
11. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
[TBL] [Abstract][Full Text] [Related]
12. Absolute bioavailability of glimepiride (Amaryl) after oral administration.
Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
Drug Metabol Drug Interact; 1994; 11(4):331-9. PubMed ID: 12369756
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
14. The disposition and bioavailability of intravenous and oral nalbuphine in healthy volunteers.
Lo MW; Schary WL; Whitney CC
J Clin Pharmacol; 1987 Nov; 27(11):866-73. PubMed ID: 3429694
[TBL] [Abstract][Full Text] [Related]
15. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs.
Baxter JG; Brass C; Schentag JJ; Slaughter RL
J Pharm Sci; 1986 May; 75(5):443-7. PubMed ID: 3735080
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
Bastain W; Boyce MJ; Stafford LE; Morton PB; Clarke DA; Marlow HF
Eur J Clin Pharmacol; 1988; 34(5):469-73. PubMed ID: 2904884
[TBL] [Abstract][Full Text] [Related]
18. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
19. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
20. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
